Pharmaceutical Technology

JUNE 15, 2023

Japan-based Astellas Pharma has entered a partnership with Cullgen to discover and develop multiple targeted protein degraders through the latter’s proprietary uSMITE targeted protein degradation platform, in a deal potentially worth $1.9bn. This method can target enzymes, transcription factors, scaffold proteins and more.

Protein 130

Protein Development Licensing Licensing 130

Pharmaceutical Technology

MARCH 21, 2023

Gilead Sciences has exercised its option to exclusively license the investigational targeted protein degrader development candidate, NX‑0479, from clinical-stage biopharmaceutical company Nurix Therapeutics. Additionally, Nurix will receive up to low double-digit tiered royalties on the net sales of the product.

Protein 130

Protein Licensing Licensing Sales 130

XTalks

JULY 26, 2023

Brevel , an Israeli startup specializing in the conversion of microalgae into alternative proteins, recently secured $18.5 The Tel Aviv-based startup will use the new funding to deliver an alternative protein source that is neutral in taste, highly functional, remarkably sustainable and accessible to the broader food industry.

Protein 97

Protein Production Cosmetics Marketing 97

Pharmaceutical Technology

SEPTEMBER 14, 2022

API peptides and proteins-based drugs have gained much attention in the past decade. Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. Discover the top API protein and peptide companies in contract marketing. Technologies in the delivery of peptides and proteins.

Protein 100

Protein Marketing Manufacturing Reagent 100

Fierce Pharma

NOVEMBER 8, 2024

With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach to protein production as a potential salve.

Protein 72

Protein Production Manufacturing Development 72

Medical Xpress

APRIL 21, 2023

A new publication released today in The EMBO Journal identified a key protein in the molecular mechanism triggering neurogenesis in the hippocampus. They found that tight regulation of Yap1 activity is essential as dysregulation can cause tissue disruption seen in the early stages of brain cancer.

Protein 102

Protein Production Regulation Research 102

Pharmaceutical Technology

MAY 30, 2023

SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, SKYCovion. SKYCovion, a protein-based vaccine created in collaboration with GSK’s pandemic adjuvant, is suitable for storage between 2° and 8° Celsius.

Vaccine 298

Vaccine Vaccination Protein Medicine 298

pharmaphorum

JULY 27, 2022

Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection against SARS-CoV-2 variants. The post Pfizer takes COVID jab with ‘enhanced’ spike protein into phase 2 appeared first on.

Protein 122

Protein Immune Response Vaccination Vaccine 122

Pharmaceutical Technology

MAY 17, 2023

Antisense therapies are designed for destroying mRNA, reducing the amount of disease-causing protein. They will also have the potential to treat diseases that are caused by too little protein by increasing production, thus restoring the protein to normal levels.

Development 246

Development Protein RNA Genetics 246

Pharmaceutical Technology

APRIL 6, 2023

Biotheryx and Incyte have signed an agreement for identifying and developing targeted protein degraders for historically undruggable oncology targets. Biotheryx will also receive up to $347m in potential future regulatory and commercial milestone payments, along with tiered single-digit royalties on net product sales across the globe.

Protein 130

Protein Development Sales Production 130

Pharmaceutical Technology

MARCH 5, 2025

coli expression system, EffiX, designed to enhance the production of recombinant proteins and pDNA. WuXi Biologics has launched the E.

Protein 147

Protein Production 147

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295

Pharmaceutical Technology

MAY 9, 2023

The companies will use the natural product discovery capabilities of Ginkgo Bioworks to expedite the discovery and development of new therapeutic molecules to address diseases with high unmet patient needs.

Development 261

Development Protein Sales Production 261

Pharmaceutical Technology

JUNE 24, 2022

The protein-based vaccine is engineered from the genetic sequence of the SARS-CoV-2 virus’ initial strain. Developed utilising Novavax’s recombinant nanoparticle technology to generate antigen obtained from the coronavirus spike (S) protein, the vaccine is also formulated with the company’s saponin-based Matrix-M adjuvant. “As

Vaccine 263

Vaccine Vaccination Clinical Trials Clinical Trials 263

Pharmaceutical Technology

SEPTEMBER 7, 2022

A recombinant replication-deficient adenovirus vectored vaccine, iNCOVACC has a prefusion stabilised spike protein and is claimed to be the first intranasal vaccine globally to obtain primary two-dose schedule approvals. It is formulated to permit intranasal delivery via nasal drops.

Vaccine 263

Vaccine Vaccination Clinical Trials Clinical Trials 263

Pharmaceutical Technology

NOVEMBER 11, 2022

The European Commission (EC) has granted approval for Sanofi and GSK ’s monovalent, recombinant-protein-based, adjuvanted Covid-19 vaccine, VidPrevtyn Beta, as a booster in adults aged 18 years and above. It is indicated as a booster in people of this age group who were earlier inoculated with a Covid-19 vaccine.

Vaccination 246

Vaccination Vaccine Immune Response Protein 246

Pharmaceutical Technology

SEPTEMBER 5, 2022

The National Medical Products Administration of China (NMPA) has approved CanSino Biologics ’ (CanSinoBIO) recombinant Covid-19 vaccine (Adenovirus Type 5 Vector) for inhalation, Convidecia Air, as a booster. This vaccine leverages the same adenovirus vector technological platform as Convidecia, the intramuscular version.

Vaccine 264

Vaccine Vaccination Genetic Engineering Clinical Trials 264

Pharmaceutical Technology

APRIL 21, 2023

In return, Twist is entitled to receive an upfront payment along with annual maintenance fees, as well as fees per product, subject to the accomplishment of specific clinical and commercial milestones. The company is also expected to receive royalty payments on sales of the product.

Antibody 264

Antibody Licensing Licensing Protein 264

XTalks

JUNE 8, 2023

Ever After Foods’ unique breakthrough lies in its proprietary bioreactor setup, which has the potential to tackle the central challenge of escalating cultivated meat production. Recent research suggests that cultivated meat is more sustainable than traditional animal products, especially when coupled with renewable energy use.

Production 98

Production Protein Marketing Branding 98

Camargo

NOVEMBER 29, 2021

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Definition of Biologic Products. These products can be derived from humans, animals, or microorganisms with biotechnology.

Development 180

Development Protein Production Hormones 180

Bio Pharma Dive

JANUARY 29, 2024

A successor medicine to Sarepta's Exondys 51 appeared better at boosting dystrophin protein production, but was associated with electrolyte imbalances.

Protein 148

Protein Medicine Production 148

XTalks

JANUARY 3, 2024

As we step into 2024, the food industry is buzzing with the introduction of innovative new food products. These high-protein, low-sugar bars offer a portable and keto-friendly snack option. This year is poised to be an exciting year for food enthusiasts, with these innovative new food products hitting the shelves.

Production 103

Production Protein Hormones Packaging 103

XTalks

MARCH 31, 2023

By growing high quality crystal structures of protein-based therapeutics under microgravity, researchers can gain better insights into their complex structures and stability. The proteins will be analyzed back on Earth using techniques such as X-ray diffraction and compared with crystals from the same biologics grown on Earth.

Protein 97

Protein Research Development Manufacturing 97

World of DTC Marketing

DECEMBER 29, 2020

First, a novel approach was used that didn’t require traditional vaccine production in cell cultures or eggs. Once introduced into the human body, the protein-making machinery uses this genetic material in our cells to churn out the coronavirus “spike protein,” triggering an immune response.

Vaccination 307

Vaccination Vaccine Development Clinical Trials 307

Pharmaceutical Technology

APRIL 22, 2024

Develop a stable cell line for high-titer rAAV production with Ultragenyx's patented method involving HDAC inhibitors and AAV rep proteins. Explore the groundbreaking patent now!

Development 130

Development Protein Production 130

XTalks

FEBRUARY 29, 2024

Dual-function fusion proteins represent a cutting-edge approach in biopharmaceutical research, offering a promising avenue for the development of novel therapeutics in the treatment of complex diseases such as cancer and autoimmune disorders. At the helm of this venture is Dr. Taylor H. How is your lead program differentiated?

Protein 94

Protein Development Clinical Trials Clinical Trials 94

Pharmaceutical Technology

MARCH 11, 2024

Market-leading HCP analysis, as well as other process-related impurity analysis, is becoming smoother

Protein 100

Protein Production Marketing 100

Pharmaceutical Technology

DECEMBER 23, 2022

As per the prior and expanded agreements, ProQR is entitled to get research, development and commercialisation milestone payments totalling up to nearly $3.75bn, apart from tiered royalty payments on sales of products. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Genetics 328

Genetics Medicine Development Gene Therapy 328

XTalks

NOVEMBER 6, 2024

Gelteq’s formulations enable the delivery of various active ingredients like branched-chain amino acids, protein, caffeine and essential minerals, opening applications in sports performance, nutrition and therapeutic use.

Drug Delivery 104

Drug Delivery Drugs Bioequivalency Bioavailability 104

BioPharma Reporter

JANUARY 24, 2023

CDMO AGC Biologics will produce Tzield (teplizumab-mzwv), a recently-approved T1D treatment from Provention Bio, at its Seattle protein biologics manufacturing site.

Production 97

Production Protein Manufacturing 97

XTalks

SEPTEMBER 7, 2023

She gives examples of other products for lactose intolerance on the market, including Lactaid and Almond Breeze, but explains why Intoleran is different. The team commends this company for creating an innovative product that allows those with lactose intolerance to enjoy baked goods without sacrifices.

Production 105

Production Marketing Branding Protein 105

Pharma Mirror

APRIL 21, 2024

With the rapid development of biotechnology and molecular medicine, the introduction of mRNA as a vaccine or therapeutic agent enables the production of almost any desired functional protein/peptide within the human body.

In-Vitro 130

In-Vitro Drugs Genetic Disease RNA 130

Pharmaceutical Technology

MARCH 10, 2023

In an email to Pharmaceutical Technology , an NHSBT spokesperson said the centre will “support early phase clinical trials and preclinical work, providing a route to eventual commercial scale production”. The NHSBT representative explained that a lack of manufacturing spaces led to delays in production slots for many gene therapy developers.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

Medical Xpress

FEBRUARY 22, 2023

The results are reported in an article published in the journal Probiotics and Antimicrobial Proteins. A daily dose of a strain of brewer's yeast used to produce cachaça (distilled spirit made from fermented sugarcane juice) can act as a preventive against asthma, according to a Brazilian study involving male mice.

Production 98

Production Protein Research 98

Pharmaceutical Technology

DECEMBER 8, 2022

The delivery of the product is anticipated to begin early next year. Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer.

Licensing 305

Licensing Licensing Gene Therapy Gene 305

Pharmaceutical Technology

JUNE 21, 2023

In the past year, Hemgenix has been granted approval by the US Food and Drug Administration (FDA) and has received conditional marketing authorisation from the European Commission (EC) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This followed positive results from CSL’s Phase III HOPE-B trial (NCT03569891).

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

Pharmaceutical Technology

SEPTEMBER 2, 2022

A group of ailments, haemoglobinopathies is associated with an irregular production or structure of the haemoglobin protein in the red blood cells. The deal is in line with the company’s strategy to complement and expedite its scientific presence and pipeline in haemoglobinopathies.

Clinical Trials 264

Clinical Trials Clinical Trials Protein Trials 264